Kenneth Bate Aveo Pharmaceuticals, Inc. (AVEO) insider trading activity

AVEO Quotes by TradingView

Kenneth Bate is Director of AVEO PHARMACEUTICALS, INC.. Currently has a direct ownership of 375 shares of AVEO, which is worth approximately $0. The most recent transaction as insider was on Jan 19, 2023, when has been sold 375 shares (Common Stock) at a price of $15.0 per share, resulting in proceeds of $5,625. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 375
0% 3M change
0% 12M change
Total Value Held $0

KENNETH BATE Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 19 2023
SELL
Sale (or disposition) back to the issuer
$5,625 $15.0 p/Share
375 Reduced 50.0%
375 Common Stock

Also insider at

ATXS
Astria Therapeutics, Inc. Healthcare
Director
EPZM
Epizyme, Inc. Healthcare
Director
MDGL
MADRIGAL PHARMACEUTICALS, INC. Healthcare
GNCA
GENOCEA BIOSCIENCES, INC. Healthcare
Director
KB

Kenneth Bate

Director
Cambridge, MA

Track Institutional and Insider Activities on AVEO

Follow AVEO PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AVEO shares.

Notify only if

Insider Trading

Get notified when an Aveo Pharmaceuticals, Inc. insider buys or sells AVEO shares.

Notify only if

News

Receive news related to AVEO PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AVEO